demonstrated that the combination of the fatty acid amide hydrolase (FAAH) inhibitor URB597 with the ferroptosis inducer RSL3 effectively modulates the PI3K-AKT signaling pathway, enhancing RCC cell sensitivity to ferroptosis and significantly inhibiting tumor growth and metastasis (61). Here, FAAH is linked to renal cell carcinoma.